InSilico Medicine Cayman TopCo (HKG:3696)
Hong Kong · Delayed Price · Currency is HKD 38.94
+0.94 (2.47%)
Nov 10, 2026, 4:08 PM HKT
HKG:3696 Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, HKG:3696 stock has a consensus rating of "Strong Buy" and an average price target of $81.37. The average 1-year stock price forecast is 108.96% higher than the current stock price, while the lowest is $70.99 (+82.31%) and the highest is $100.01 (+156.83%).
Price Target: $81.37 (+108.96%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Sep 18, 2026.
Analyst Ratings
The average analyst rating for HKG:3696 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 6 | 6 | 7 | 7 |
| Buy | 1 | 1 | 2 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 8 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst KeyBanc No rating | KeyBanc | Buy Maintains $86.50 | Buy | Maintains | $86.50 | +122.14% | Sep 18, 2026 |
Unknown Analyst Citi No rating | Citi | Buy Initiates $85.00 | Buy | Initiates | $85.00 | +118.28% | Sep 3, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Buy Maintains $71.00 | Buy | Maintains | $71.00 | +82.33% | Sep 2, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $77.00 | Buy | Maintains | $77.00 | +97.74% | Aug 28, 2026 |
Unknown Analyst Guosheng Securities No rating | Guosheng Securities | Buy Maintains $81.90 | Buy | Maintains | $81.90 | +110.32% | Aug 14, 2026 |
Financial Forecast
Revenue This Year
188.77M
from 56.24M
Increased by 235.66%
Revenue Next Year
248.78M
from 188.77M
Increased by 31.79%
EPS This Year
0.14
from -0.56
EPS Next Year
0.22
from 0.14
Increased by 64.12%
EPS and Forward PE are based on non-GAAP adjusted numbers.